61
TITLE: Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential  Full Text
AUTHORS: Hélio Belo; Gabriela Silva; Bruno A Cardoso; Beatriz Porto; Jordi Minguillon; José Barbot; Jorge Coutinho; Jose A Casado; Manuela Benedito; Hema Saturnino; Emília Costa; Juan A Bueren; Jordi Surralles; Antonio Almeida;
PUBLISHED: 2015, SOURCE: PLOS ONE - PLoS ONE, VOLUME: 10, ISSUE: 10
INDEXED IN: CrossRef
IN MY: ORCID
63
TITLE: CLINICAL FACTORS PREDISPOSING TO ACHIEVEMENT OF RBC TRANSFUSION INDEPENDENCEIN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES) WITHOUT DEL(5q) IN MDS-005 STUDY  Full Text
AUTHORS: Santini, V; Shiansong S S Li; Swern, AS; Almeida, A; Giagounidis, A; Fu, T; Sanna, A; Hoenekopp, A; Beach, CL; Skikne, B; Fenaux, P;
PUBLISHED: 2015, SOURCE: 45th Congress of the Italian-Society-of-Hematology in HAEMATOLOGICA, VOLUME: 100
INDEXED IN: WOS
IN MY: ORCID
64
TITLE: STUDY PHASE 3 OF LENALIDOMIDE (LEN) IN PATIENTS (PTES) WITH MYELODYSPLASTIC SYNDROME (SMD) WITHOUT DEL(5Q) OF LOW RISK AND WITH TRANSFUSIONAL DEPENDENCE (DT), REFRACTORIES OR NON RESPONSIVE TO STIMULATING AGENTS OF ERYTHROPOIESIS  Full Text
AUTHORS: Del Canizo, MC; Almeida, A; Giagounidis, A; Fenaux, P; Santini, V; Ozawa, K;
PUBLISHED: 2015, SOURCE: 57th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy in HAEMATOLOGICA, VOLUME: 100
INDEXED IN: WOS
IN MY: ORCID
65
TITLE: Safety of Lenalidomide (LEN) 10mg in Non-Del(5q) Versus Del(5q) in the Treatment of Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS): Pooled Analysis of Treatment-Emergent Adverse Events (TEAEs)
AUTHORS: Almeida, A; Santini, V; Cropper, S; Jonasova, A; Vey, N; Giagounidis, A; Hellstrom Lindberg, E; Mufti, GJ; Sanz, G; Skikne, B; Hoenekopp, A; Seguy, F; Zhong, JH; Fenaux, P;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: WOS CrossRef: 1
IN MY: ORCID
66
TITLE: Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry
AUTHORS: Antonio Medina Almeida; Camille L Bedrosian; Alexander Cole; Petra Muus; Hubert Schrezenmeier; Jeff Szer; Alvaro Urbano Ispizua; Wendell F Rosse;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: WOS
67
TITLE: Different Clinical Characteristics of Paroxysmal Nocturnal Hemoglobinuria in Pediatric and Adult Patients
AUTHORS: Alvaro Urbano Ispizua; Petra Muus; Hubert Schrezenmeier; Antonio Medina Almeida; Amanda Vilson; Russell E Ware;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: WOS
68
TITLE: REAL-WORLD EVIDENCE OF IRON CHELATION THERAPY IN TRANSFUSION DEPENDENT MDS PATIENTS: A PORTUGUESE HOSPITAL REGISTRY
AUTHORS: Rodrigues, S; Almeida, A; Viriato, D; Antunes, M ;
PUBLISHED: 2015, SOURCE: 18th ISPOR Annual European Congress in VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS CrossRef
IN MY: ORCID
69
TITLE: THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MDS: RESULTS FROM THE MDS-005 TRIAL  Full Text
AUTHORS: Santini, V; Almeida, A; Giagounidis, A; Bartiromo, C; Hoenekopp, A; Guo, S; Beach, CL; Altincatal, A; Wu, C; Skikne, B; Zhong, J; Hu, XH; Fenaux, P;
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
70
TITLE: A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)  Full Text
AUTHORS: Santini, V; Almeida, A; Giagounidis, A; Groepper, S; Jonasova, A; Vey, N; Mufti, GJ; Buckstein, R; Mittelman, M; Platzbecker, U; Shpilberg, O; Ram, R; del Canizo, C; Gattermann, N; Ozawa, K; Risueno, A; MacBeth, KJ; Zhong, J; Seguy, F; Hoenekopp, A; Beach, CL; Fenaux, P; ...More
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
IN MY: ORCID
Page 7 of 8. Total results: 77.